Answer
Ultomiris (ravulizumab) home infusions may be considered after good clinic tolerance and the treating physician’s evaluation and recommendation, and must be given by a qualified healthcare professional under supervision of a physician experienced in haematological, renal, neuromuscular or neuroinflammatory disorders.
Sources for this answer
- Ultomiris 300 mg/3 mL and 1100 mg/11 mL PLGB 31187/0007Alexion Pharma UK Ltd · emc · SmPC §4.2 Posology and method of administration · Version 12Document updated
Sources checked